Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Panvac-VF (falimarev/inalimarev)
i
Other names:
CV-301, CVAC-301, CEA-MUC-1-TRICOM, vaccinia-carcinoembryonic antigen (CEA)- mucin-1 (MUC-1)- triad of costimulatory molecules (TRICOM) vaccine, CV301, CEA-MUC-1/TRICOM, MVA-BNCV301/FPVCV301
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Bavarian Nordic, National Cancer Institute - Bethesda
Drug class:
MUC1 inhibitor, CEA inhibitor
Related drugs:
‹
gatipotuzumab (5)
BTH1704 (0)
AR20.5 (0)
ETBX-061 (0)
GO-203-2c (0)
GT-00A x IL15 (0)
VXL100 (0)
ONT-10 (0)
PDC*lung (0)
tecemotide (0)
Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine (0)
activated CIK and bispecific antibody (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
TG4010 (0)
TLX66 (0)
BA1202 (0)
ETBX-011 (0)
GI-6207 (0)
RG6123 (0)
SENTI-401 (0)
RG7802 (0)
gatipotuzumab (5)
BTH1704 (0)
AR20.5 (0)
ETBX-061 (0)
GO-203-2c (0)
GT-00A x IL15 (0)
VXL100 (0)
ONT-10 (0)
PDC*lung (0)
tecemotide (0)
Undisclosed MUC1 peptide-poly-ICLC adjuvant vaccine (0)
activated CIK and bispecific antibody (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
TG4010 (0)
TLX66 (0)
BA1202 (0)
ETBX-011 (0)
GI-6207 (0)
RG6123 (0)
SENTI-401 (0)
RG7802 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.